Literature DB >> 27017374

Evidence of cerebrospinal fluid abnormalities in patients with depressive syndromes.

Dominique Endres1, Evgeniy Perlov2, Rick Dersch3, Annette Baumgartner3, Tilman Hottenrott3, Benjamin Berger3, Oliver Stich3, Ludger Tebartz van Elst2.   

Abstract

BACKGROUND: Depression is the most prevalent psychiatric disease. In addition to primary, idiopathic depression, there are multiple secondary organic forms. However, distinguishing the two can be difficult, information about cerebrospinal fluid (CSF) basic findings in patients with depressive syndromes is sparse. Therefore, we investigated CSF alterations in so far the largest sample of patients with depressive syndromes. We hypothesized that increased prevalence of CSF pleocytosis, blood-brain-barrier (BBB) dysfunction, and oligoclonal bands (OCBs) would be observed as possible markers of underlying immunological processes.
METHODS: From January 2006 until October 2013, we performed CSF basic diagnostics in 125 patients with depressive syndromes. We also performed serum and CSF autoantibody measurements, cerebral magnetic resonance imaging (cMRI) and electroencephalography (EEG).
RESULTS: Four % of the patients displayed increased CSF white blood cell counts (WBC), 46.4% had increased protein concentrations, and 19.4% had pathological albumin quotients. OCBs in the CSF were detected in 6.5%. Overall, CSF basic diagnostics were abnormal in 56%. Including instrument-based diagnostics, we found alterations in 80.8% of patients. Suicidal tendencies correlated with an increased WBC count (r=0.276, p=0.002). LIMITATIONS: In this open, uncontrolled study, we investigated mainly CSF samples of depressive patients with signs of organic features. Therefore, the study cohort is not representative of idiopathic depression.
CONCLUSIONS: The main findings of this study are the high rates of pathological (although mainly unspecific) CSF findings. We discuss the findings regarding possible immunological mechanisms and the vascular depression hypothesis. If these findings are associated with low-level inflammation of the central nervous system, new treatment alternatives could be considered. More and better controlled research is necessary.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood-brain-barrier-dysfunction; Cerebrospinal fluid; Depressive syndrome; Immunological encephalopathy

Mesh:

Substances:

Year:  2016        PMID: 27017374     DOI: 10.1016/j.jad.2016.03.030

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  11 in total

1.  An inflammatory profile linked to increased suicide risk.

Authors:  Sarah A Keaton; Zachary B Madaj; Patrick Heilman; LeAnn Smart; Jamie Grit; Robert Gibbons; Teodor T Postolache; Kimberly Roaten; Eric D Achtyes; Lena Brundin
Journal:  J Affect Disord       Date:  2019-01-03       Impact factor: 4.839

2.  Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies.

Authors:  Dominique Endres; Sebastian Rauer; Nils Venhoff; Patrick Süß; Rick Dersch; Kimon Runge; Bernd L Fiebich; Kathrin Nickel; Miriam Matysik; Simon Maier; Katharina Domschke; Karl Egger; Harald Prüss; Ludger Tebartz van Elst
Journal:  Front Psychiatry       Date:  2020-08-13       Impact factor: 4.157

3.  Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression.

Authors:  Ludger Tebartz van Elst; Dominique Endres; Maike Michel; Bernd L Fiebich; Hanna Kuzior; Sophie Meixensberger; Benjamin Berger; Simon Maier; Kathrin Nickel; Kimon Runge; Dominik Denzel; Benjamin Pankratz; Miriam A Schiele; Katharina Domschke
Journal:  Transl Psychiatry       Date:  2021-05-21       Impact factor: 6.222

4.  Alterations in Cerebrospinal Fluid in Patients with Bipolar Syndromes.

Authors:  Dominique Endres; Rick Dersch; Tilman Hottenrott; Evgeniy Perlov; Simon Maier; Dietrich van Calker; Benedikt Hochstuhl; Nils Venhoff; Oliver Stich; Ludger Tebartz van Elst
Journal:  Front Psychiatry       Date:  2016-12-08       Impact factor: 4.157

5.  Schizophrenia Associated with Epileptiform Discharges without Seizures Successfully Treated with Levetiracetam.

Authors:  Dominique Endres; Evgeniy Perlov; Bernd Feige; Dirk-Matthias Altenmüller; Nils Venhoff; Ludger Tebartz van Elst
Journal:  Front Psychiatry       Date:  2017-02-08       Impact factor: 4.157

Review 6.  What is the significance of onconeural antibodies for psychiatric symptomatology? A systematic review.

Authors:  Sverre Georg Sæther; Morten Schou; Daniel Kondziella
Journal:  BMC Psychiatry       Date:  2017-05-03       Impact factor: 3.630

7.  IL1R2, CCR2, and CXCR4 May Form Heteroreceptor Complexes with NMDAR and D2R: Relevance for Schizophrenia.

Authors:  Dasiel O Borroto-Escuela; Alexander O Tarakanov; Karl Bechter; Kjell Fuxe
Journal:  Front Psychiatry       Date:  2017-02-15       Impact factor: 4.157

8.  Ethical Implications of the Mild Encephalitis Hypothesis of Schizophrenia.

Authors:  Rita Riedmüller; Sabine Müller
Journal:  Front Psychiatry       Date:  2017-03-13       Impact factor: 4.157

9.  Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.

Authors:  Sonja Orlovska-Waast; Ole Köhler-Forsberg; Sophie Wiben Brix; Merete Nordentoft; Daniel Kondziella; Jesper Krogh; Michael Eriksen Benros
Journal:  Mol Psychiatry       Date:  2018-08-16       Impact factor: 15.992

10.  A prospective three-year follow-up study on the clinical significance of anti-neuronal antibodies in acute psychiatric disorders.

Authors:  M B Schou; S G Sæther; O K Drange; E Brenner; J Crespi; L Eikenes; M S Mykland; C Pintzka; A K Håberg; T Sand; A Vaaler; D Kondziella
Journal:  Sci Rep       Date:  2019-12-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.